244 related articles for article (PubMed ID: 34771681)
1. Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery.
Payne K; Brooks JM; Taylor GS; Batis N; Noyvert B; Pan Y; Nankivell P; Mehanna H
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771681
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer.
Chudziak J; Burt DJ; Mohan S; Rothwell DG; Mesquita B; Antonello J; Dalby S; Ayub M; Priest L; Carter L; Krebs MG; Blackhall F; Dive C; Brady G
Analyst; 2016 Jan; 141(2):669-78. PubMed ID: 26605519
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the epithelial-mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma.
Payne K; Brooks J; Batis N; Taylor G; Nankivell P; Mehanna H
Head Neck; 2022 Nov; 44(11):2545-2554. PubMed ID: 35932094
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
Philippron A; Depypere L; Oeyen S; De Laere B; Vandeputte C; Nafteux P; De Preter K; Pattyn P
PLoS One; 2021; 16(5):e0251052. PubMed ID: 33961658
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping.
Payne K; Brooks J; Batis N; Khan N; El-Asrag M; Nankivell P; Mehanna H; Taylor G
Br J Cancer; 2023 Nov; 129(10):1590-1598. PubMed ID: 37735243
[TBL] [Abstract][Full Text] [Related]
6. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
[TBL] [Abstract][Full Text] [Related]
7. Direct comparison of size-dependent versus EpCAM-dependent CTC enrichment at the gene expression and DNA methylation level in head and neck squamous cell carcinoma.
Zavridou M; Mastoraki S; Strati A; Koutsodontis G; Klinakis A; Psyrri A; Lianidou E
Sci Rep; 2020 Apr; 10(1):6551. PubMed ID: 32300118
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumour cells in metastatic head and neck cancers.
Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C
Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
[TBL] [Abstract][Full Text] [Related]
10. Role of circulating tumour cells (CTCs) in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC).
Baa AK; Sharma A; Bhaskar S; Biswas A; Thakar A; Kumar R; Jayant S; Aland G; D'Souza A; Jadhav V; Bharde A; Khandare J; Pramanik R
Ecancermedicalscience; 2023; 17():1578. PubMed ID: 37533950
[TBL] [Abstract][Full Text] [Related]
11. Novel method for highly multiplexed gene expression profiling of circulating tumor cells (CTCs) captured from the blood of women with metastatic breast cancer.
Farhang Ghahremani M; Seto KKY; Cho W; Miller MC; Smith P; Englert DF
J Transl Med; 2023 Jun; 21(1):414. PubMed ID: 37365600
[TBL] [Abstract][Full Text] [Related]
12. Antigen-agnostic microfluidics-based circulating tumor cell enrichment and downstream molecular characterization.
Cohen EN; Jayachandran G; Hardy MR; Venkata Subramanian AM; Meng X; Reuben JM
PLoS One; 2020; 15(10):e0241123. PubMed ID: 33095819
[TBL] [Abstract][Full Text] [Related]
13. Capture of Circulating Tumour Cell Clusters Using Straight Microfluidic Chips.
Kulasinghe A; Zhou J; Kenny L; Papautsky I; Punyadeera C
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30646614
[TBL] [Abstract][Full Text] [Related]
14. CTC together with Shh and Nrf2 are prospective diagnostic markers for HNSCC.
Rahman MM; Hossain MM; Islam S; Ahmed R; Majumder M; Dey S; Kawser M; Sarkar B; Himu MER; Chowdhury AA; Ahmed S; Biswas S; Anwar MM; Hussain MJ; Kumar Shil R; Baidya S; Parial R; Islam MM; Bharde A; Jayant S; Aland G; Khandare J; Uddin SB; Noman ASM
BMC Mol Cell Biol; 2024 Feb; 25(1):4. PubMed ID: 38336617
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of circulating tumor cells in blood using a collection device with a preservative reagent.
Qin J; Alt JR; Hunsley BA; Williams TL; Fernando MR
Cancer Cell Int; 2014 Mar; 14(1):23. PubMed ID: 24602297
[TBL] [Abstract][Full Text] [Related]
16. IsoMAG-An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells.
Gribko A; Stiefel J; Liebetanz L; Nagel SM; Künzel J; Wandrey M; Hagemann J; Stauber RH; Freese C; Gül D
Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829387
[TBL] [Abstract][Full Text] [Related]
17. Diversity of Epithelial-Mesenchymal Phenotypes in Circulating Tumour Cells from Prostate Cancer Patient-Derived Xenograft Models.
Hassan S; Blick T; Thompson EW; Williams ED
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34206049
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance.
Reinhardt F; Franken A; Meier-Stiegen F; Driemel C; Stoecklein NH; Fischer JC; Niederacher D; Ruckhaeberle E; Fehm T; Neubauer H
Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31261643
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients.
Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B
Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504
[TBL] [Abstract][Full Text] [Related]
20. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
